1. Home
  2. |Insights
  3. |Dealmakers Breakfast Series: How Dealmaking in the Health Care Industry is Evolving

Dealmakers Breakfast Series: How Dealmaking in the Health Care Industry is Evolving

Event | 09.27.18, 4:30 AM EDT - 6:00 AM EDT

Address

Grant Thornton LLP
757 Third Avenue, 9th Floor, New York, NY

Crowell & Moring LLP and Grant Thornton LLP invite you to join us for a breakfast panel discussion on how dealmaking in the health care industry is evolving.

Despite regulatory and policy uncertainty and the emergence of highly disruptive business models, M&A activity continues its record-setting pace, and valuation multiples continue to climb across all sectors of health care. During this program, we will discuss the most significant issues affecting the health care industry, how buyers are evaluating and finding value, and what’s on the horizon for dealmakers investing in this space.

Hosts:

Moderator:

  • Lance Beder, Partner, Transaction Services Health Care Leader, Grant Thornton 

Panelists:

  • Mark Cabrera, Managing Director, Co-Head of Health Care, Oppenheimer & Co. 
  • Robin Shah, Former Flatiron Health Executive 
  • Bill Case, Partner, Clearview Capital 
  • Jodi Daniel, Partner, Health Care Group, Crowell & Moring
Dealmakers Breakfast Series
The Dealmakers Breakfast Series programs are invitation only and focused on senior-level professionals from private equity funds, family office groups, and other institutional investors.

For more information, please contact:

Mae Hsieh, Crowell & Moring LLP
mhsieh@crowell.com | 212.895.4241

Miriam Oh, Grant Thornton LLP
miriam.oh@us.gt.com | 917.742.8662

For more information, please visit these areas: Corporate and Transactional

Insights

Event | 12.04.25

ACI 30th Annual Conference on Drug & Medical Device Litigation

Dan Campbell with Speak on the panel "Mastering MDL Case Management: What Proposed Rule 16.1 Really Means for Consolidated Litigation."
Rule 16.1 attempts to guide early case management in MDLs, impacting litigation pace and costs. Permissive language like “should” instead of “must”, could lead to inconsistent applications. This panel will explore the rule’s anticipated impact and implications for procedures.